|1.||Takahara, Shiro: 4 articles (12/2012 - 02/2007)|
|2.||Imamura, Ryoichi: 4 articles (12/2012 - 02/2007)|
|3.||Ichimaru, Naotsugu: 4 articles (12/2012 - 02/2007)|
|4.||Isaka, Yoshitaka: 4 articles (12/2012 - 02/2007)|
|5.||Vcelar, Brigitta: 3 articles (03/2013 - 09/2011)|
|6.||Okumi, Masayoshi: 3 articles (12/2012 - 01/2008)|
|7.||Nonomura, Norio: 3 articles (12/2012 - 01/2008)|
|8.||Okuyama, Akihiko: 3 articles (01/2012 - 02/2007)|
|9.||Brines, Michael: 3 articles (11/2006 - 04/2006)|
|10.||Schelzig, Hubert: 2 articles (03/2013 - 09/2011)|
|2.||Brain Injuries (Brain Injury)
09/01/2011 - "Compared to traumatic brain injury-saline rats, traumatic brain injury-carbamylated erythropoietin rats showed improved functional recovery of the acute somatomotor reflexes post traumatic brain injury, took less time to remove adhesive from the forelimbs, and showed higher percentages of correct avoidance responses. "
02/01/2011 - "Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury."
03/01/2008 - "Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury."
04/01/2006 - "Carbamylated erythropoietin reduces radiosurgically-induced brain injury."
09/01/2011 - "Carbamylated erythropoietin can thus be considered as a potential agent in the treatment of traumatic brain injury-induced diffuse edema."
|3.||Brain Edema (Cerebral Edema)
09/01/2011 - "Our findings indicate that early posttraumatic administration of carbamylated erythropoietin reduces brain edema development until at least 6 hrs postinjury and improves neurologic recovery. "
09/01/2011 - "Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative."
09/01/2011 - "Compared to traumatic brain injury-saline rats, rats receiving traumatic brain injury-carbamylated erythropoietin showed a significant reduction in brain edema formation at 1 hr that was sustained until 6 hrs when results were comparable with sham-operated rats. "
09/01/2011 - "Three series of experiments were conducted to investigate: 1) the effect of carbamylated erythropoietin on brain edema before and 1 hr after traumatic brain injury using diffusion-weighted magnetic resonance imaging and measurements of apparent diffusion coefficient (n = 10 rats per group), and the phosphorylation level of brain extracellular-regulated kinase-1/-2 was also determined to indicate the presence of an activated cell signaling pathway; 2) the time course of brain edema using magnetic resonance imaging between 4 and 6 hrs postinjury and the gravimetric technique at 6 hrs (n = 10 rats per group); and 3) motor and cognitive function over 10 days post traumatic brain injury, testing acute somatomotor reflexes, adhesive paper removal, and two-way active avoidance (n = 8 rats per group). "
09/01/2011 - "To investigate the effects of carbamylated erythropoietin, a modified erythropoietin lacking erythropoietic activity, on brain edema and functional recovery in a model of diffuse traumatic brain injury. "
|4.||Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
07/01/2006 - "Chronic treatment with asialo erythropoietin (ASIALO-EPO) or carbamylated erythropoietin (CEPO) improved motor behavior and reduced motoneuron loss and astrocyte and microglia activation in the cervical spinal cord of wobbler mice, an animal model of amyotrophic lateral sclerosis, but had no effect on hematocrit values. "
|5.||Parkinson Disease (Parkinson's Disease)
03/28/2013 - "The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease."
03/28/2013 - "In this study we evaluated the neuroprotective/rescue effects of erythropoietin Fc fusion protein (EPO-Fc) and carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease. "
|2.||Choline O-Acetyltransferase (Choline Acetyltransferase)
|3.||salicylhydroxamic acid (SHAM)
|5.||Sodium Chloride (Saline Solution)
|8.||darbepoetin alfa (Aranesp)